MC-Val-Cit-PAB-Retapamulin
MC-Val-Cit-PAB-Retapamulin is an antibody-drug conjugate (ADC) linker-payload featuring the ribosomal inhibitor Retapamulin. This cleavable conjugate is designed for targeted cancer therapy research, enabling the study of ADC efficacy and mechanism in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1639793-15-9
Field of Research
Pharmacology & Drug Discovery
Smiles
[H][C@@]12C (=O) CC[C@]11CC[C@@H] (C) [C@@]2 (C) [C@@H] (C[C@@] (C) (C=C) [C@@H] (O) [C@@H]1C) OC (=O) CS[C@H]1C[C@@H]2CC[C@H] (C1) [N@@+]2 (C) Cc1ccc (NC (=O) [C@H] (CCCNC (N) =O) NC (=O) [C@@H] (NC (=O) CCCCCN2C (=O) C=CC2=O) C (C) C) cc1 |c:73, TLB:27:28:35:31.32,36:35:28.34.29:31.32, THB:37:35:28.34.29:31.32|
Molecular Formula
C58H86N7O10S
Molecular Weight
1073.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
